Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-5 of 5 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
1-Nov-2019The comparative effects of high dose atorvastatin and proprotein convertase subtilisin/kexin type 9 inhibitor on the mitochondria of oxidative muscle fibers in obese-insulin resistant female ratsChanisa Thonusin; Nattayaporn Apaijai; Thidarat Jaiwongkam; Sasiwan Kerdphoo; Busarin Arunsak; Patchareeya Amput; Siripong Palee; Wasana Pratchayasakul; Nipon Chattipakorn; Siriporn C. Chattipakorn
1-Aug-2020PCSK9 inhibitor and atorvastatin reduce cardiac impairment in ovariectomized prediabetic rats via improved mitochondrial function and Ca<sup>2+</sup> regulationPatchareeya Amput; Siripong Palee; Busarin Arunsak; Wasana Pratchayasakul; Chanisa Thonusin; Sasiwan Kerdphoo; Thidarat Jaiwongkam; Siriporn C. Chattipakorn; Nipon Chattipakorn
15-Aug-2020Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor exerts greater efficacy than atorvastatin on improvement of brain function and cognition in obese ratsBusarin Arunsak; Wasana Pratchayasakul; Patchareeya Amput; Kenneth Chattipakorn; Theetouch Tosukhowong; Sasiwan Kerdphoo; Thidarat Jaiwongkum; Chanisa Thonusin; Siripong Palee; Nipon Chattipakorn; Siriporn C. Chattipakorn
1-Oct-2020A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived ratsChanisa Thonusin; Patcharapong Pantiya; Thidarat Jaiwongkam; Sasiwan Kerdphoo; Busarin Arunsak; Patchareeya Amput; Siripong Palee; Wasana Pratchayasakul; Nipon Chattipakorn; Siriporn C. Chattipakorn
15-Sep-2020PCSK9 inhibitor effectively attenuates cardiometabolic impairment in obese-insulin resistant ratsPatchareeya Amput; Siripong Palee; Busarin Arunsak; Wasana Pratchayasakul; Sasiwan Kerdphoo; Thidarat Jaiwongkam; Siriporn C. Chattipakorn; Nipon Chattipakorn